EP0261233A4 - Immortalized virus-specific tissue cells. - Google Patents

Immortalized virus-specific tissue cells.

Info

Publication number
EP0261233A4
EP0261233A4 EP19870903002 EP87903002A EP0261233A4 EP 0261233 A4 EP0261233 A4 EP 0261233A4 EP 19870903002 EP19870903002 EP 19870903002 EP 87903002 A EP87903002 A EP 87903002A EP 0261233 A4 EP0261233 A4 EP 0261233A4
Authority
EP
European Patent Office
Prior art keywords
tissue cells
specific tissue
immortalized
virus
immortalized virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19870903002
Other languages
German (de)
French (fr)
Other versions
EP0261233A1 (en
Inventor
Steven K H Foung
Linda B Rabin
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Genelabs Inc
Original Assignee
Genelabs Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genelabs Inc filed Critical Genelabs Inc
Publication of EP0261233A1 publication Critical patent/EP0261233A1/en
Publication of EP0261233A4 publication Critical patent/EP0261233A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • A61K39/29Hepatitis virus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/12Viral antigens
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5767Immunoassay; Biospecific binding assay; Materials therefor for hepatitis non-A, non-B hepatitis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24222New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011Details
    • C12N2770/24011Flaviviridae
    • C12N2770/24211Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
    • C12N2770/24234Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP19870903002 1986-04-01 1987-04-01 Immortalized virus-specific tissue cells. Withdrawn EP0261233A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US84675786A 1986-04-01 1986-04-01
US846757 1986-04-01

Publications (2)

Publication Number Publication Date
EP0261233A1 EP0261233A1 (en) 1988-03-30
EP0261233A4 true EP0261233A4 (en) 1988-08-29

Family

ID=25298865

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19870903002 Withdrawn EP0261233A4 (en) 1986-04-01 1987-04-01 Immortalized virus-specific tissue cells.

Country Status (4)

Country Link
EP (1) EP0261233A4 (en)
JP (1) JPS63502962A (en)
AU (1) AU613310B2 (en)
WO (1) WO1987005930A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5218099A (en) * 1986-04-01 1993-06-08 The United States Of America As Represented By The Department Of Health And Human Services Post-transfusion, non-A, non-B hepatitis virus polynucleotides
US5712088A (en) * 1987-11-18 1998-01-27 Chiron Corporation Methods for detecting Hepatitis C virus using polynucleotides specific for same
US5698390A (en) 1987-11-18 1997-12-16 Chiron Corporation Hepatitis C immunoassays
US5350671A (en) * 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
CN1049686C (en) * 1987-11-18 2000-02-23 希龙股份有限公司 Nanbv diagnostics and vaccines
US5714596A (en) * 1987-11-18 1998-02-03 Chiron Corporation NANBV diagnostics: polynucleotides useful for screening for hepatitis C virus
US6171782B1 (en) 1987-11-18 2001-01-09 Chiron Corporation Antibody compositions to HCV and uses thereof
US6861212B1 (en) 1987-11-18 2005-03-01 Chiron Corporation NANBV diagnostics and vaccines
JPH04501203A (en) * 1988-07-06 1992-03-05 ジェネラブズ インコーポレイティド Post-transfusion-borne, non-A, non-B hepatitis viruses and antigens
EP0460056A4 (en) * 1989-02-24 1992-06-24 Southwest Foundation For Biomedical Research Non-a, non-b hepatitis hepatocyte cell culture
US6027729A (en) * 1989-04-20 2000-02-22 Chiron Corporation NANBV Diagnostics and vaccines
DE69031791T2 (en) * 1989-08-25 1998-04-02 Chiron Corp Process for HCV cultivation in cell lines from B or T lymphocytes
CA2079677A1 (en) * 1990-04-03 1991-10-04 Kenneth H. Burk Purified hcv and hcv proteins and peptides
EP1018558A3 (en) * 1990-04-06 2002-06-05 Genelabs Technologies, Inc. Hepatitis C Virus Epitopes
WO1994025064A1 (en) * 1993-05-04 1994-11-10 THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMANSERVIC ES Hepatitis c virus cell propagation and related methods
WO1996024662A1 (en) * 1995-02-10 1996-08-15 Consiglio Nazionale Delle Ricerche Process to 'in vitro' propagate the hepatitis c virus (hcv) in non lymphoblastoid animal cell cultures and products thereof
GB201119011D0 (en) * 2011-11-03 2011-12-14 Queen Mary Innovation Ltd Method
WO2023239928A1 (en) * 2022-06-09 2023-12-14 CHO Plus Inc. Cell hybrids as host cells for high efficiency production of gene therapy vectors and viral vaccines

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001131A1 (en) * 1985-08-19 1987-02-26 Gene Labs, Inc. Non-human primate monoclonal antibodies and methods
WO1987005929A1 (en) * 1986-04-01 1987-10-08 Genelabs Incorporated Immortalized cells which produce tissue-specific products

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4040905A (en) * 1971-10-27 1977-08-09 The United States Government Sub-human primate diploid cell lines as substrates for virus vaccine production
US4164566A (en) * 1978-08-17 1979-08-14 Merck & Co., Inc. Hepatitis a virus cell culture in vitro
US4395395A (en) * 1979-05-21 1983-07-26 The United States Of America As Represented By The Department Of Health And Human Services Detection of non-A, non-B hepatitis associated antigen
US4491632A (en) * 1979-10-22 1985-01-01 The Massachusetts General Hospital Process for producing antibodies to hepatitis virus and cell lines therefor
US4464474A (en) * 1980-07-09 1984-08-07 Connaught Laboratories Limited Non-A, non-B hepatitis assay and vaccine
US4621053A (en) * 1980-07-30 1986-11-04 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Process for the production of human peptide hormones
US4542016A (en) * 1981-03-27 1985-09-17 Institut Merieux Non-a non-b hepatitis surface antigen useful for the preparation of vaccines and methods of use
US4474893A (en) * 1981-07-01 1984-10-02 The University of Texas System Cancer Center Recombinant monoclonal antibodies
CH652145A5 (en) * 1982-01-22 1985-10-31 Sandoz Ag METHOD FOR IN VITRO PRODUCTION OF HYBRID OMEN WHAT human monoclonal antibodies GENERATE.
US4438098A (en) * 1982-01-27 1984-03-20 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Heat treatment of a non-A, non-B hepatitis agent to prepare a vaccine
US4574116A (en) * 1983-01-13 1986-03-04 The Board Of Trustees Of The Leland Stanford Jr. University Methods and cell lines for immortalization and monoclonal antibody production by antigen-stimulated B-lymphocytes
US4574166A (en) * 1983-02-04 1986-03-04 At&T Bell Laboratories Tandem adaptive filter arrangement
FR2545100B1 (en) * 1983-04-29 1985-12-20 Inst Nat Sante Rech Med PROCESS FOR OBTAINING CULTURES OF HUMAN HEPATOCYTES, THE CULTURES OBTAINED AND THEIR BIOLOGICAL AND BIOCHEMICAL APPLICATIONS
US4634666A (en) * 1984-01-06 1987-01-06 The Board Of Trustees Of The Leland Stanford Junior University Human-murine hybridoma fusion partner
FR2565995B1 (en) * 1984-03-07 1987-10-23 Centre Nat Rech Scient HYBRID CELLS PRODUCING A DETERMINED POLYPEPTIDE AND OBTAINED FROM PRIMARY CELLS NATURALLY CAPABLE OF EXPRESSING THIS POLYPEPTIDE OR AN EQUIVALENT POLYPEPTIDE, PROCESS FOR OBTAINING SUCH HYBRID CELLS, AND APPLICATION THEREOF TO THE PRODUCTION THEREOF

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987001131A1 (en) * 1985-08-19 1987-02-26 Gene Labs, Inc. Non-human primate monoclonal antibodies and methods
WO1987005929A1 (en) * 1986-04-01 1987-10-08 Genelabs Incorporated Immortalized cells which produce tissue-specific products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO8705930A1 *

Also Published As

Publication number Publication date
EP0261233A1 (en) 1988-03-30
WO1987005930A1 (en) 1987-10-08
JPS63502962A (en) 1988-11-02
AU7238387A (en) 1987-10-20
AU613310B2 (en) 1991-08-01

Similar Documents

Publication Publication Date Title
GB2191332B (en) Electrochemical cell
GB2200639B (en) Acellular red blood cell substitute
ZA871695B (en) Membrane
EP0261233A4 (en) Immortalized virus-specific tissue cells.
GB2187590B (en) Electrochemical cells
GB2191333B (en) Electrochemical cell
GB2192305B (en) Electrochemical cell
GB8606479D0 (en) Incubator
GB8613798D0 (en) Electrolyte
EP0237941A3 (en) Incubator
GB8726423D0 (en) Membrane keyboard
GB8706406D0 (en) Mediators for bio-electrochemical cells
GB8608053D0 (en) Membrane
GB8711693D0 (en) Membrane keyboard
GB8709639D0 (en) Electrochemical cells
ZA875899B (en) Electrochemical cell
PT85828A (en) Cell transfection
GB8725065D0 (en) Membrane
EP0271085A3 (en) Deferred-action cell
GB8717796D0 (en) Donor sheet
GB8611131D0 (en) Cells
SU1374711A1 (en) Solid electrolyte
GB8624438D0 (en) Electrolytoc cell
GB8612651D0 (en) Cell culture
GB2196171B (en) Electrochemical cell

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19871202

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19880829

17Q First examination report despatched

Effective date: 19910307

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19921013

RIN1 Information on inventor provided before grant (corrected)

Inventor name: RABIN, LINDA, B.

Inventor name: FOUNG, STEVEN, K., H.